AzTrials
AzTrials

Lower Eyelid BagsPhase 2NCT07766902

The Effect of Inhalation Aromatherapy on Intraoperative Fear in Patients Undergoing Lower Blepharoplasty Under Local Anesthesia: A Randomized Controlled Trial

A Phase 2 study testing inhaled aromatherapy in people with Lower Eyelid Bags, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a single-center, randomized, controlled, open-label clinical trial designed to evaluate the intervention effect of inhaled aromatherapy on intraoperative fear in patients undergoing lower blepharoplasty (eyelid bag surgery) under local anesthesia. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Lower Eyelid Bags
What is being tested?
inhaled aromatherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
152 participants
Where
1 siteChina
Study dates
1 Aug 2026to 31 Mar 2027
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-65 years, either sex
  • Scheduled for elective bilateral lower blepharoplasty (eyelid bag surgery)
  • Anesthesia: pure local anesthesia (lidocaine and/or ropivacaine) without any sedative agents
  • ASA physical status I-II
  • Alert and oriented, able to understand and complete questionnaires correctly
  • Normal olfactory function (able to distinguish among coffee, alcohol, and vanilla)
  • Voluntary participation with signed informed consent

Who cannot join

  • History of allergy to lavender essential oil or any botanical essential oil
  • Diagnosed olfactory disorder, chronic rhinitis, asthma, COPD, or other respiratory diseases
  • Preoperative use of anxiolytics, sedatives, or opioid analgesics
  • History of psychiatric disorders, cognitive impairment, or needle phobia (trypanophobia)
  • Pregnant or breastfeeding women
  • Participation in another clinical trial within the past month
  • Any other condition deemed by the investigator as unsuitable for study participation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yun Ge Sun Yat-sen Memorial Hospital, Sun Yat-sen University contact

020-34070349

geyun@mail.sysu.edu.cn

China1 site
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510120

    Yun Ge Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 020-34070349, geyun@mail.sysu.edu.cn

Other trials in China

About this study

This study is a single-center, randomized, controlled, open-label clinical trial designed to evaluate the intervention effect of inhaled aromatherapy on intraoperative fear in patients undergoing lower blepharoplasty (eyelid bag surgery) under local anesthesia.

Read the detailed description

This study is a single-center, randomized, controlled, open-label clinical trial designed to evaluate the intervention effect of inhaled aromatherapy on intraoperative fear in patients undergoing lower blepharoplasty (eyelid bag surgery) under local anesthesia. A total of 152 adult patients scheduled for elective bilateral lower blepharoplasty under pure local anesthesia (lidocaine and/or ropivacaine) without any sedative agents will be enrolled. Patients will be randomly assigned in a 1:1 ratio to either the experimental group (inhaled aromatherapy) or the control group (standard care). The primary outcome is the intraoperative fear score measured by the Visual Analogue Scale for Fear (VAS-Fear). Secondary outcomes include fear score during local anesthetic injection, pain during local anesthetic injection, changes in state anxiety, intraoperative cooperation, surgical satisfaction, and changes in physiological parameters. Lavender essential oil will be used for aromatherapy, and patients may choose to use it voluntarily. An intensified intervention protocol (forward positioning of the cotton pad + nurse hand-holding + breathing guidance) will be implemented during the critical period of local anesthetic injection. This study will be conducted in accordance with the Declaration of Helsinki and will commence after approval by the Ethics Committee. All participants will provide written informed consent.

Being tested
inhaled aromatherapy
Keywords
Lower eyelid bags, lower blepharoplasty, inhaled aromatherapy, intraoperative fear score, fear score during local anesthetic injection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • inhaled aromatherapyOther

    A sterile cotton ball with 2 drops of lavender essential oil was placed 10 cm from the nose

Study groups in NCT07766902
Study groupRoleWhat they receive
inhaled aromatherapyExperimentalA sterile cotton ball with 2 drops of lavender essential oil was placed 10 cm from the nose
Receives: Other: inhaled aromatherapy
ControlNo interventionNo intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intraoperative fear score

    intraoperative fear score measured by the Visual Analogue Scale for Fear (VAS-Fear)

    Measured: 1 day

Secondary outcomes (6)
  1. VAS-Fear score during local anesthetic injection

    VAS-Fear score during local anesthetic injection

    Measured: 1 day

  2. Visual Analogue Sacle for Pain (VAS-Pain) score during local anesthetic injection

    VAS-Pain score during local anesthetic injection

    Measured: 1 day

  3. changes in state anxiety

    State-Trait Anxiety Inventory (STAI) Score (including STAI-State and STAI-Trait) is measured 30 minutes before surgery, immediately before surgery, and immediately after surgery completetion

    Measured: 1 day

  4. intraoperative cooperation

    A 1-5 scale (from extreme poor cooperation to excellent cooperation) for subjective evaluation of surgical cooperation by the surgeon

    Measured: 1 day

  5. surgical satisfaction

    A 1-5 scale (from very dissatisfied to very satisfied) for subjective evaluation of surgical satisfaction by the patient as well as VAS-Satisfaction score, which are measured immediately after surgery and 1 day after surgery

    Measured: 1 day

  6. changes in physiological parameters

    changes in physiological parameters (including heart rate, blood pressure, blood oxygen saturation, et. al.) immediately before and immediately after surgery completition

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2026
  2. Study start1 Aug 2026 (estimated)
  3. Primary completion31 Mar 2027 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
152 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07766902
Sponsor's protocol ID
SYSKY-2026-441-02
Status last verified
Jul 2026
First submitted
22 Jul 2026
Last updated
17 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chang M, Schaefer J, Leonard A, Ellison PR, Cui R, Evans R, Calvert N, Thuro B, Fay A, Nguyen J. The Effect of Aromatherapy on Anxiety and Pain in Patients Undergoing Oculoplastic Surgery. Ophthalmic Plast Reconstr Surg. 2024 Nov-Dec 01;40(6):677-680. doi: 10.1097/IOP.0000000000002692. Epub 2024 May 22.

    PubMed 38776147

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing inhaled aromatherapy in people with Lower Eyelid Bags, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yun Ge Sun Yat-sen Memorial Hospital, Sun Yat-sen University (020-34070349, geyun@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intraoperative fear score (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07766902, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in